Emphasizing ease of installation and a cloud-based service, Cleerly said its new Proxy software allows smooth transmission of coronary computed tomography angiography (CCTA) scans between interdisciplinary clinicians caring for patients with heart disease.
As a possible alternative to navigating the intricacies of different systems and radiology workflows at multiple facilities, Cleerly has launched Proxy software that provides automated transmission of coronary computed tomography angiography (CCTA) scans from local facility systems to a cloud-based service.
The company said Proxy can be utilized for the receipt of CCTA scans from multiple imaging and vendor neutral archive (VNA) modalities as well as picture archiving and communication systems (PACS). Clinicians can subsequently obtain the CCTA scans from the Cleerly cloud service to review the imaging findings or discuss results with patients.
Distributed as an open visualization appliance (OVA) file, Proxy can reportedly be installed and launched in five minutes, according to Cleerly.
Cleerly added that the setup for Proxy includes access to remote implementation specialists for questions regarding Proxy configuration, testing and initial use of digital imaging and communications medicine (DICOM) uploads.
“With Proxy, our goal is to be completely seamless and allow providers to better treat their heart patients,” noted James Min, M.D., FACC, FESC, MSCCT, the founder and CEO of Cleerly. “The addition of Proxy to our portfolio will decrease the time in which providers receive our (artificial intelligence) AI-based quantifiable disease analysis with a tool that fits directly into their workflows. This virtual appliance is another way we are improving how heart disease is identified, prevented, and treated.”
(Editor's note: For related articles, see "Deep Learning Improves CT Guidance for Revascularization of Coronary Total Occlusions" and "HeartFlow Garners FDA Clearance for Two AI-Powered Tools with CCTA.")
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.